Searched for
GOA FDA
Experts back OTC access to NRT across all formats and dosages, including 2 mg and 4 mg, as India struggles with a Tobacco quit success rate under 5%The report highlights the significant economic burden of tobacco use, particularly among low-income households, and underscores how reducin...- Lupin receives USFDA EIR for Goa facility with VAI statusDrug maker Lupin said it has received an Establishment Inspection Report from the US Food and Drug Administration for its Goa-based manufac...
- Goa civic body bans sale of 'gobi manchurian' at street stalls over concerns about hygieneThe municipal council of Mapusa town in North Goa has banned the sale of 'gobi manchurian' at roadside stalls due to concerns about unhygie...
- Now, you won't get Gobi Manchurian in this Goa town. Here's whyThe Mapusa Municipal Council in Goa has banned Gobi Manchurian, a popular fusion dish, due to concerns about poor hygiene, synthetic colors...
- Abbott India warns of laxatives shortage in tussle with Goa regulatorAbbott Laboratories' Indian unit has warned of potential supply shortages of two popular laxative syrups, Cremaffin and Duphalac, after pro...
- Implementing corrective actions at Goa unit; stopped Digene production at the facility: AbbottThe drug regulatory body also advised doctors and healthcare professionals to carefully prescribe and educate their patients to discontinue...
- Lupin shares jump 10% in a sudden move; here's whyThe US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI), the Mumbai-headquartered ...
- Plan to approach USFDA for re-inspection of key plants in next few months: LupinThe US drug regulator, after inspecting the two sites, had expressed concerns over quality-control procedures that include handling of out-...
- Lupin gets EIR from USFDA for Pithampur facilityIn November last, Lupin had received warning letter from USFDA (US Food and Drug Administration) for its manufacturing facilities in Goa an...
- USFDA issues 6 observations post Indoco's Goa plant inspectionThe United States Food and Drug Administration (USFDA) inspected the company's Goa Plant II from August 31, 2016 to September 4, 2016, Indo...
- Committed to close corrective action at Goa by December: LupinIt said that even if the US Food and Drug Administration decides to hold back approvals from the Goa facility it won't have much impact on ...
- Lupin slips nearly 7% on CLSA downgrade, target price cutLupin shares crashed earlier this week after the USFDA has issued nine observations related to manufacturing practices at its Goa-based for...
- Lupin shares fall may be overdone as review minorBut a closer reading of the FDA observations show that they could be of a minor nature and may not lead to any significant impact on earnin...
- Nestle shares end 8% higher after FSSAI lab finds Maggi safeAfter surging 10.17 per cent to Rs 7,000 in intra-day trade, shares of the company finally ended at Rs 6,831.95, up 7.53 per cent on the BS...
- FSSAI-approved lab finds Maggi noodles safeFSSAI-approved laboratory of Central Food Technological Research Institute has found Maggi noodles to be in compliance with the food safety...
- Lupin's Goa unit comes under USFDA scannerLupin has come under US regulatory probe for deviations from good manufacturing practices, some of which may include serious deviations.
- Goa FDA asks Nestle to recall Maggi stock from 709 outletsThe recall has been ordered as per the instructions of Food Safety and Standards Authority of India, which has issued circulars to all the ...
- USFDA officials to visit India this month; to sign pactHigh-ranking officials of US health regulator USFDA will be travelling to India later this month to meet their senior regulatory counterpar...
- Lupin recalls blood pressure drug in USLupin Ltd is recalling one batch of high blood pressure (BP) tablets losartan potassium from the US market after it exceeded the permissibl...
- We’re enhancing our capacity to 10 bn tablets: Aditi Kare Panandikar, Indoco RemediesET Now catches up with Aditi Kare Panandikar, Indoco Remedies Ltd, for her views on the formulation drugmaker’s production network, FDA app...
Load More
